AUIYX
Price
$35.95
Change
-$0.06 (-0.17%)
Updated
Aug 19 closing price
Net Assets
639.77M
VIVIX
Price
$70.65
Change
+$0.33 (+0.47%)
Updated
Aug 19 closing price
Net Assets
195.81B
Interact to see
Advertisement

AUIYX vs VIVIX

Header iconAUIYX vs VIVIX Comparison
Open Charts AUIYX vs VIVIXBanner chart's image
AB Equity Income Advisor
Price$35.95
Change-$0.06 (-0.17%)
VolumeN/A
Net Assets639.77M
Vanguard Value Index I
Price$70.65
Change+$0.33 (+0.47%)
VolumeN/A
Net Assets195.81B
AUIYX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AUIYX vs. VIVIX commentary
Aug 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUIYX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 196B vs. AUIYX (640M). VIVIX pays higher dividends than AUIYX: VIVIX (2.19) vs AUIYX (1.37). AUIYX was incepted earlier than VIVIX: AUIYX (29 years) vs VIVIX (27 years). AUIYX (0.65) is less costly to investors than VIVIX (0.04). AUIYX is a more actively managed with annual turnover of: 42.00 vs. VIVIX (9.00). AUIYX has a lower initial minimum investment than VIVIX: AUIYX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 7.59 vs. AUIYX (5.86). VIVIX return over 5 years is better than : 70.23 vs. AUIYX (47.27).
AUIYXVIVIXAUIYX / VIVIX
Total Expense Ratio0.650.041,625%
Annual Report Gross Expense Ratio0.650.041,625%
Fund Existence29 years27 years-
Gain YTD10.9016.548166%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets640M196B0%
Annual Yield % from dividends1.372.1963%
Returns for 1 year5.867.5977%
Returns for 3 years29.2327.04108%
Returns for 5 years47.2770.2367%
Returns for 10 years66.43127.4552%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PDSB1.240.05
+4.20%
PDS Biotechnology Corp
MASI153.930.06
+0.04%
Masimo Corp
TAVIU10.54N/A
N/A
Tavia Acquisition Corp
IMCR32.31-0.57
-1.73%
Immunocore Holdings plc
TNXP40.07-11.28
-21.97%
Tonix Pharmaceuticals Holding Corp